BluePill AI platform enables brands to test products, messaging, and creative concepts in minutes.
BluePill has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
BluePill's investors include David Wickwire, Flying Fish Partners, Pioneer Square Labs, Ubiquity Ventures, David Spector.
BluePill is headquartered in Seattle, United States.
BluePill AI platform enables brands to test products, messaging, and creative concepts in minutes.
BluePill is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BluePill — Funding & Investors." VCBacked, November 17, 2025, https://www.vcbacked.co/company/bluepill. Accessed October 31, 2026.
VCBacked. (2025). BluePill — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/bluepill
{{cite web |title=BluePill — Funding & Investors |url=https://www.vcbacked.co/company/bluepill |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated